Terms: = Breast cancer AND LMNA, EMD2, 4000, ENSG00000160789, LGMD1B, LDP1, PRO1, LMNC, FPLD, CDDC, HGPS, P02545, LFP, IDC, CMD1A, CDCD1, LMN1, CMT2B1, FPL AND Clinical Outcome
37 results:
1. clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
Yin L; Yin AH; Pu CC
BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
[TBL] [Abstract] [Full Text] [Related]
2. Does concomitant ductal carcinoma in situ affect the clinical outcome in breast cancer patients with invasive ductal carcinoma: An Asian perspective.
Lee WP; Shetty SS; Seah CMJ; Tan PT; Tan SM
Cancer Rep (Hoboken); 2022 Sep; 5(9):e1646. PubMed ID: 35892151
[TBL] [Abstract] [Full Text] [Related]
3. Validation of prognostic significance of the proposed uniform classification framework in neuroendocrine neoplasms of the breast.
Yang L; Roy M; Lin H; Shen Y; Albarracin C; Huo L; Chen H; Wei B; Bedrosian I; Bu H; Wu Y
Breast Cancer Res Treat; 2021 Apr; 186(2):403-415. PubMed ID: 33528758
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological characteristics and survival outcomes in breast carcinosarcoma: A SEER population-based study.
Lin S; Liu C; Tao Z; Zhang J; Hu X
Breast; 2020 Feb; 49():157-164. PubMed ID: 31812891
[TBL] [Abstract] [Full Text] [Related]
5. Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
Kassardjian A; Shintaku PI; Moatamed NA
PLoS One; 2018; 13(4):e0195958. PubMed ID: 29672601
[TBL] [Abstract] [Full Text] [Related]
6. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer.
Mercogliano MF; Inurrigarro G; De Martino M; Venturutti L; Rivas MA; Cordo-Russo R; Proietti CJ; Fernández EA; Frahm I; Barchuk S; Allemand DH; Figurelli S; Deza EG; Ares S; Gercovich FG; Cortese E; Amasino M; Guzmán P; Roa JC; Elizalde PV; Schillaci R
BMC Cancer; 2017 Dec; 17(1):895. PubMed ID: 29281999
[TBL] [Abstract] [Full Text] [Related]
7. Loss of FAT1 during the progression from DCIS to idc and predict poor clinical outcome in breast cancer.
Wang L; Lyu S; Wang S; Shen H; Niu F; Liu X; Liu J; Niu Y
Exp Mol Pathol; 2016 Feb; 100(1):177-83. PubMed ID: 26721716
[TBL] [Abstract] [Full Text] [Related]
8. Runx2 Expression as a Potential Prognostic Marker in Invasive Ductal breast Carcinoma.
El-Gendi SM; Mostafa MF
Pathol Oncol Res; 2016 Jul; 22(3):461-70. PubMed ID: 26597806
[TBL] [Abstract] [Full Text] [Related]
9. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
[TBL] [Abstract] [Full Text] [Related]
10. Pathological features and prognosis of lobular carcinoma in Egyptian breast cancer patients.
Azim HA; Malek RA; Azim HA
Womens Health (Lond); 2014 Sep; 10(5):511-8. PubMed ID: 25335542
[TBL] [Abstract] [Full Text] [Related]
11. Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4.
Fernandez P; Scaffidi P; Markert E; Lee JH; Rane S; Misteli T
Cell Rep; 2014 Oct; 9(1):248-260. PubMed ID: 25284786
[TBL] [Abstract] [Full Text] [Related]
12. Absence of caveolin-1 expression in carcinoma-associated fibroblasts of invasive micropapillary carcinoma of the breast predicts poor patient outcome.
Ren M; Liu F; Zhu Y; Li Y; Lang R; Fan Y; Gu F; Zhang X; Fu L
Virchows Arch; 2014 Sep; 465(3):291-8. PubMed ID: 24980157
[TBL] [Abstract] [Full Text] [Related]
13. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract] [Full Text] [Related]
14. The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer.
Wazir U; Ahmed MH; Bridger JM; Harvey A; Jiang WG; Sharma AK; Mokbel K
Cell Mol Biol Lett; 2013 Dec; 18(4):595-611. PubMed ID: 24293108
[TBL] [Abstract] [Full Text] [Related]
15. FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast.
Lal A; Chan L; Devries S; Chin K; Scott GK; Benz CC; Chen YY; Waldman FM; Hwang ES
Breast Cancer Res Treat; 2013 Jun; 139(2):381-90. PubMed ID: 23712790
[TBL] [Abstract] [Full Text] [Related]
16. Impact of different tumour stroma assessment methods regarding podoplanin expression on clinical outcome in patients with invasive ductal breast carcinoma.
Pula B; Wojnar A; Werynska B; Ambicka A; Kruczak A; Witkiewicz W; Ugorski M; Podhorska-Okolow M; Dziegiel P
Anticancer Res; 2013 Apr; 33(4):1447-55. PubMed ID: 23564785
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of tumor budding in invasive breast cancer.
Liang F; Cao W; Wang Y; Li L; Zhang G; Wang Z
Pathol Res Pract; 2013 May; 209(5):269-75. PubMed ID: 23561623
[TBL] [Abstract] [Full Text] [Related]
18. clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (idc).
Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
[TBL] [Abstract] [Full Text] [Related]
19. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
[TBL] [Abstract] [Full Text] [Related]
20. Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population.
Cao AY; Huang L; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM; Di GH
World J Surg Oncol; 2012 Jul; 10():152. PubMed ID: 22805492
[TBL] [Abstract] [Full Text] [Related]
[Next]
